Results for tag: "Methyl Aminolevulinate"

Methyl Aminolevulinate (MAL) is a photosensitizing drug used in photodynamic therapy (PDT) for the treatment of certain types of cancer. PDT is a minimally invasive procedure that uses light and a photosensitizing drug to destroy cancer cells. MAL is a prodrug that is converted to a photosensitizer, protoporphyrin IX (PpIX), when exposed to light. PpIX is then activated by light, producing reactive oxygen species that damage the cancer cells. MAL is used to treat cancers of the bladder, esophagus, head and neck, and skin. MAL is a relatively new drug, and the market is still in its early stages. The drug is approved in several countries, including the United States, Europe, and Japan. The market is expected to grow in the coming years due to increasing awareness of PDT and the availability of new drugs. Some companies in the MAL market include Galderma, Photocure, and Photocure ASA. Show Less Read more